drugset / Trial / NCT03827408

Nebulized Midazolam, Dexmedetomidine, and Their Combination in Sedation of Preschoolers Undergoing Dental Treatment

NCT03827408

Phase 2 Completed 72 enrolled Nourhan M.Aly Alexandria University · collab
RandomizedParallel-groupQuadruple-blindOther

Summary

The aim of the study is to evaluate the effect of nebulized Midazolam, Dexmedetomidine, and their combination as procedural, moderate sedative agents in preschoolers undergoing dental treatment.

Timeline

Start
2017-11-27
Primary completion
2019-08-29
Completion
2019-12-22

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 3 ug/kg Other
Subject Dexmedetomidine Other / unclassified 5 ug/kg Other
Comparator Midazolam Small molecule 0.3 mg/kg Other
Comparator Midazolam Small molecule 0.5 mg/kg Other

Indications

No indication recorded.